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This study aims to investigate the effect of Phyllanthus niruri Linn 
(Euphorbiaceae) in the proliferation of human leukemic cells (MOLT-4 and 
K562). Phyllanthus niruri L (P.niruri) was macerated by using various 
solvents to obtain the crude extracts. Citotoxicity of the extracts against 
MOLT-4 and K562 cells was tested using MTT assay to find the IC50 value. To 
analyse cell cycle progression, cellular DNA was measured using propidium 
iodide (PI) staining. Apoptosis induction was evaluated using Annexin V-FITC 
and PI staining and was analysed using FACSVerse flow cytometry. Finally, 
the expression of p53 on MOLT-4 and K562 cell lysate was measured using 
western blotting, to identify the possible mode of action of anticancer activity. 
P. niruri crude extracts demonstrated a potential anticancer effect towards 
MOLT-4 cells (IC50 range was 42.21±4.98 to 97.06±18.29µg/mL). However, 
against K562 cells, P.niruri extracts exhibited a lower inhibitory potency (the 
IC50 was 120.19±8.48 to 256.55±26.22µg/mL). The results showed the 
selectivity of the toxic effect of the extracts against MOLT-4 and K562.  To 
evaluate the possible mechanism of action of the anticancer effect, we 
evaluated P. niruri extract action in apoptosis induction and p53 expression. 
The results showed that methanol and hexane extract inhibited MOLT-4 cell 
progression from G1 to S-phase, indicating G1 cell arrest. Moreover, apoptotic 
cell population following treatment of MOLT-4 and K562 cells with methanol 
extract was markedly increased, showing morphological signs of apoptosis 
including membrane degradation and chromatin condensation. Furthermore, 
we found that there was an increase in p53 expression following                  
MOLT-4 treatment with methanol extract, suggesting that p53 induction 
might be involved in cell apoptosis. The results indicated the involvement                  
of p53 pathway in the mechanism of anti-cancer activity exerted                                    
by P. niruri extract on MOLT-4 cells. However, on cancer cells lacking P53 
expression, such as K562 cells, apoptosis might take place via other 
pathways. 




Since the earliest time, herbal and plant-
originated medicines have been exploited for 
cancer treatment, as recorded in many medicine 
ancient manuscripts (Nobili, et al., 2009). This 
practice is still widely used during the modern era, 
as plant-derived natural compounds have given a 
new hope in cancer treatment by showing a 
potency in killing cancerous cells with less side 
effects (Newman and Cragg, 2007; Nobili, et al., 
2009). Plant-derived medicine has also set a 
fundamental discovery of several important 
chemotherapy agents such as vincristine, 
irinothecan, etoposide, and paxitacle (Nobili, et al., 
2009).   
Phyllanthus niruri Linn (P. niruri) is one of 
widely-used medicinal plants in traditional 
medicine practices, which has demonstrated a 
variety of pharmacological effects in treating many 
symptoms (Puspita, 2015; Sabir and Rocha, 2008). 
From many years of phytochemical studies, 
researchers   have   identified  more  than 50 active 
constituents of P. niruri, such as flavonoids (Sabir 
and Rocha, 2008), terpenes (Bagalkotkar, et al., 
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2006), coumarines (Iizuka, et al., 2007), lignans 
(Syamasundar et al., 1985), tannins (Than, et al., 
2006), saponins, and alkaloids (Sahni et al., 2005). 
This herb has been extensively studied to evaluate 
the ethnopharmacological use in treating jaundice, 
hypertension, urolithisis, and diabetes. A number 
of literatures has recorded the therapeutic effects 
of phytochemicals isolated from P. niruri, including 
hepatoprotective, antioxidant, antihyperuricemic, 
and antihyperlipodemic activities. For the last few 
years, researchers have shown a growing interest 
in evaluating the pharmacological activities of this 
herb as anticancer.  P. niruri extracts were reported 
to show a potency in inhibiting cell growth and 
signalling cascade of various cancer cell lines, 
including lung cancer (A549), prostate cancer              
(PC-3), breast cancer (MCF-7), and hepatocellular 
cancer (HepG2 and Huh-7) (de Araújo Júnior, et al., 
2012; Lee, et al., 2006).   
From many years of research, no cytotoxicity 
effects of this plant to normal cells have been 
reported until recently (Than, et al., 2006). 
However, many questions remain unanswered 
regarding the bioactivity of this herb in combating 
cancer cells, particularly the efficacy against high 
resistance and recurrence cancer such as leukemia.  
Leukemia is known as one of common cancer with 
a high mortality rate owing to high recurrence rate 
and high resistance rate to chemotherapy (Horner, 
et al., 2009). As surgery is not favourable, the 
discovery of more efficient chemotherapeutic 
agents still holds a major role in the development 
of leukemia treatment.  
In comparison to the other closely related 
species, crude extracts from other Phyllanthus 
species have demonstrated anti-cancer activities 
against leukemia cell lines. For example, water 
extract from Phyllanthus urinaria was shown                       
to induce apoptosis in human myeloid                   
leukemia cells (HL–60) through a ceramide related 
pathway (Huang, et al., 2004). Phyllanthostatin, 
phytochemical isolated from the roots of 
Phyllanthus acuminatus, demonstrated a potency to 
inhibit the proliferation of murine lymphocytic 
leukemia cell line (P-388) (Pettit, et al., 1990). 
Extensive evidence has shown that, as one of the 
aims of cancer therapy, modulation of cell cycle and 
induction of apoptosis are the crucial keys in 
terminating leukemia cell proliferation. With 
regards to P.niruri bioactivity, this herb extract has 
demonstrated an ability to induce cell arrest during 
cell cycle and subsequent apoptosis in solid tumors 
such as melanoma and prostate cancer (Tang, et al., 
2010). However, despite this initial finding, study 
in identifying P. niruri effect in leukemia cells is 
very limited, as there is no report available to date 
which elucidate the efficacy of this herb in inducing 
cell cycle arrest and apoptosis in blood cancer.  
To answer these questions, in this study, we 
investigate the antiproliferative activity of P. niruri 
extracts against leukemia cell lines. Two cell lines 
from different origin, MOLT-4 and K562, are used 
in this study. MOLT-4 cell line derived from a 
patient with acute lymphoblastic leukemic, whilst 
K562 cell line were obtained from chronic myeloid 
leukemia.  Furthermore, to identify the possible 
mode of action of anti-cancer effect of P. niruri 
extracts towards leukemia cell lines, we evaluate it 
action in the cell cycle modulation, and apoptosis 
induction. 
 
MATERIAL AND METHODS 
Material 
Powdered dried P.niruri was purchased 
from PT Haldin Pacific Semesta, Indonesia. Plant 
material was produced from selected leaves of 
P.niruri (product specification is attached). The 
powder was prepared by drying and grinding the 
plant leaves. All cell lines (MOLT-4, K562, and  
swiss 3T3 albino mouse fibroblast) were obtained  
from ATCC England, UK. Culture medium (RPMI) 
and all media supplements were obtained from 
Lonza, Walkersville, MD. Cisplatin, thiazolyl blue 
tetrazolium bromide (MTT salt), Propidium Iodide 
(PI), and ribonuclease (RNAse)-A were purchased 
from Sigma-Aldrich, Dorset, UK. FITC Annexin V kit 
was obtained from BD Bioscience, Oxford, UK. 
 
Preparation of P. niruri extracts 
The extraction of P. niruri was performed by 
solvent maceration (methanol, ethanol, hexane, 
and chloroform). The extraction was started with 
100g of crude material, which was immersed in 
200mL of solvent for 24h. Next, the solvent was 
filtered, and the filtrate was collected. The residue 
was re-immersed in an equal volume of fresh 
solvent. The maceration was repeated three times. 
The dried-crude extract was obtained by drying 
process using a rotary evaporator. Each extract was 
prepared for further assays by dissolving in DMSO 
at a final concentration of less than 0.01M. 
 
Cell culture 
All cell lines were cultured in RPMI culture 
medium supplemented with 10% (v/v) Fetal 
Bovine Serum (FBS), 2mM L-glutamine, 50IU/mL 
penicillin, and 50µg/mL streptomycin. The culture 
condition was 37ᵒC with 5% CO2. 
Nanda Ayu Puspita 
Volume 30 Issue 4 (2019)  243 
MTT Assay 
In 100µL of cell suspensions (containing 105 
cells/mL) were plated in 96-wells microplate. P. 
niruri extracts, cisplatin as a positive control, and 
DMSO as a negative control, was added into each 
corresponding well. After 5 days incubation, 30µL 
of MTT solution (containing 5mg/mL of thiazolyl 
blue tetrazolium bromide) was added into each 
well. The incubation was continued for a further 4h 
(37ᵒC, 5% CO2). Prior to reading, 100µL DMSO was 
added to dissolve the formazan crystal formed in 
each well. The optical density was measured using 
a Multiskan FC® plate reader (absorbance at 
590nm and 690nm). 
 
Cell cycle analysis 
The cells were seeded at a density of 105 
cells/mL in medium containing P. niruri extracts. 
The dose used was the half maximal inhibitory 
concentration (IC50). As for the control group, the 
medium was free from P. niruri extracts.  After 
incubation for 24, 48, and 72h, the cells were 
harvested by centrifugation (250 x g for 5min). 
Subsequently, the cell pellets were washed with 
phosphate buffer saline (PBS) for three times.                
The cells were fixed in 70% (v/v) ethanol for 30min 
at 4ᵒC. After washing with PBS, RNAse A 
(100µg/mL) was added to the cell pellet and 
incubated at 37ᵒC. Finally, the cell pellets were 
stained with PI (50µg/mL) in the dark condition   
for a minimum of 30min prior to analysis                      
using FACS Verse flow cytometry (BD Bioscience, 
Oxford,  UK) at 488nm excitation and 620nm 
emission wavelengths. The histograms were 
analysed by BD FACSuiteTM software (BD 
Bioscience, Oxford, UK). 
 
Morphological studies 
Following treatment with P. niruri extract 
for 25h, cell slides were prepared from cell 
suspension (105 cells/mL) and stained with 
hematoxylin-eosin staining. Morphological change 
was observed to evaluate the signs of apoptosis 
such as plasma membrane blebbing, nuclear and 
chromatin condensations, and the appearance of 
apoptotic bodies (Harikumar, et al., 2009).  
 
Apoptosis analysis by Annexin V 
Cell staining for apoptosis assay was per-
formed      according   to   the  manufacturer’s  protocol.  
Briefly, cell pellet collected after 24h treatment 
with  methanol or cisplatin (IC50 dose)  was washed  
 
(two times) with cold PBS and re-suspend in 1x 
binding buffer (to obtain cell density of 1x106 
cells/mL). After washing, the cell pellets were 
stained with 5µL of Annexin V-FITC and 10µL of 
propidium iodide (PI) and incubated in the dark 
condition for 15min. The analysis was performed 
using a FACS Verse flow cytometry (BD Bioscience, 
Oxford, UK) 485nm excitation and 535nm emission 
wavelengths. Histogram analysis was performed by 
using BD FACSuiteTM software (BD Bioscience, 
Oxford, UK). 
 
Protein extraction and western blotting 
Cells lysis was performed using high salt 
lysis buffer (45mM Hepes, 400mM NaCl, 1mM 
EDTA, 10% glycerol, 0.5% IgePal, 2mM sodium 
orthovanadate, 5mM NaPPi, and 20mM β glycerol 
phosphate) containing protease inhibitor cocktail. 
Lysate from cells containing 50µg proteins was 
fractionated by 10 % SDS-PAGE gel and transferred 
to Polyvinyllidene fluoride (PVDF) membranes 
(Millipore, UK). The transfer process was then 
blocked in PBS containing 0.1% Tween 20 and                  
5% nonfat milk for 1h at room temperature, 
followed by incubation with primary antibody 
overnight at 4°C. On the next day, the membrane 
was washed three times in PBS containing 0.1% 
Tween 20, and then incubated with horseradish 
peroxide conjugated secondary antibody 
(Amersham, GE Healthcare) for 1h. After washing, 
1mL of SuperSignal™ West Femto Maximum 
Sensitivity Substrate (ThermoScientific, UK) was 
added for 30 seconds at room temperature. The 
bands were detected using gel imaging for 
fluorescence and chemiluminescence G: BOX 
(Syngene, UK). The densitometric measurements of 
protein levels was performed using Image J 
software (Schneider, et al., 2012). The intensity of 




Data was obtained from three independent 
experiments and presented as the mean ± Standard 
Mean Error (SEM). Statistical analysis was 
performed using Graphpad prism software version 
5.0 (GraphPad Software, San Diego California           
USA). Comparison of means was performed               
by using one-way ANOVA with Bonferroni's 
multiple comparison as a post hoc analysis. A p-
value smaller than 0.05 was considered statistically 
significant. 
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RESULTS AND DISCUSSION 
The cytotoxic effect of P. niruri extracts on 
leukaemia cell growth 
Cytotoxicity test results showed the             
potency of the extracts of P. niruri in halting                       
the proliferation of MOLT-4 cell line in a dose-
dependent manner. The lowest IC50 value                         
was 42.21±4.98 was 97µg/mL (methanol              
extract), whilst the highest IC50 06±18.29µg/mL 
(ethanol extract) (Table I). The activity shown                  
by each extract against MOLT-4, from the lowest to 
the highest potency, was ethanol < hexane < 
chloroform < methanol. Against K562 cell line, the 
P.niruri extracts also demonstrated an inhibitory 
effect on the cell proliferation. Nevertheless, the 
cytotoxic effect was lower than that shown against 
MOLT-4. The inhibitory activity of methanol extract 
on MOLT-4 cells (IC50 value 42.21±4.98 µg/mL) 
was higher than the effect on K562 cells (IC50 value 
139.28±19.02µg/mL) (Table I). Moreover, our 
results demonstrated that the IC50 of cisplatin for 
MOLT-4 and K562 cells was 0.48±0.03µg/mL and 
1.06±0.01µg/mL, respectively. The result showed 
that K562 is less susceptible towards anti-cancer 
therapy.   
The effect of the extracts on normal cell 
proliferation was also evaluated. Against 3T3 cells, 
the range of IC50 values was from 0.35±0.08µg/mL 
to >500 µg/mL. Cisplatin demonstrated the lowest 
IC50 values compared to the herb extracts                  
which means that at low dose, cisplatin has              
started to show unfavourable effect to normal cells.  
 
When the selectivity index (SI) was calculated, 
cisplatin was shown to have a low selectivity                  
on normal cells (0.73 and 0.33 for MOLT-4 and 
K562, respectively). With regards to the selectivity 
of the plant extracts, the range of SI indices was 
0.64 to >11.85 for chloroform and methanol 
extract, respectively. Chloroform extract, as it 
exerted the low antiproliferative effect on both cell 
lines tested, also showed the lowest selectivity 
indices (0.64 and 1.93). The other extracts 
provided much better selectivity indices (more 
than 4.16), which suggested that the extracts 
showed less toxic effect towards normal cells. In 
overall, methanol extract was shown to be the most 
active extract, which exerted a significant toxic 
effect with the lowest IC50 values for MOLT-4. The 
results have shown the potential anti-proliferation 
activities    of   P. niruri   extracts   against   MOLT-4.  
  
Table I. IC50 values of P. niruri extracts on cancer cell lines (Puspita, 2015) 
  
Extract 
IC50 (±SD)*( µg/mL) 
MOLT-4 K562 3T3 
Methanol 42.21±4.98 139.28±19.02 >500 
Ethanol 97.06±18.29 148.51±10.81 >500 
Hexane 89.57±3.60 120.19±8.48 >500 
Chloroform 85.08±8.57 256.55±26.22 164.31±8.42 
Cisplatin 0.48±0.03 1.06±0.01 0.35±0.08 
 
*The IC50 value was calculated using Graphpad Prism from three independent experiments (Puspita, 2015). The 
negative control used in this study was DMSO, which shown no inhibitory activity on cell proliferation at a 
concentration less than 0.1 M. 
 




Selectivy Index (SI)* 
MOLT-4 K562 
Methanol >11.85 3.59 
Ethanol >5.15 >3.37 
Hexane >5.85 >4.16 
Chloroform 1.93 0.64 
Cisplatin 0.73 0.33 
 
*The selectivity index (SI) is the ratio of the IC50 values of P.niruri extracts against 3T3 cells to the IC50 values against 
leukemia cell lines MOLT-4 and K562. 
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The low antiproliferative effect towards K562              
and high selectivity indices has suggested the 
selectivity of the anti-cancer activity of this plant.  
 
Cell cycle analysis in the presence of P. niruri 
extracts 
MOLT-4 cells treated with P. niruri extracts 
and the control groups were analysed after 24, 48, 
and 72h of incubation time. Following 24h 
incubation, the changes of cell cycle kinetic on all 
treated groups were observed (Figure 1). The 
progression of cell cycle from G1 phase to S phase 
was significantly halted as most of cell population 





Figure 1. MOLT-4cells were treated with methanol 
extract (42 µM) for 24, 48 and 72h. During G1-
phase (A), the cells are in the preparation stage for 
entering the S-phase (B), where a single round of 
DNA synthesis is taking place. After 24h treatment 
with P. niruri extract, the majority of cell population 
is arrested in G1-phase. After 24 and 72h 
incubation, celsl are accumulated in G2/M phase 
(C). Data in the graph represent the percentage of 
the viable cells from three experiment (n=3) as 
mean ± SEM. Each value was compared to the 
corresponding control group (*p<0.05, **p<0.001). 
 
After 48h, the control group has completed 
the first round of cell cycle progression, 
considering that the doubling time of MOLT-4 cells 
is 30-32h (Ma, et al., 2014). In this stage, most of the 
cell population in control group were accumulated 
in G1 phase for the preparation to S phase. 
Treatment with P.niruri extracts showed a 
variability of cell arrest phases after 48h incubation. 
Chloroform, ethanol, and hexane extracts arrested 
the cell population in G2/M phase, as most of the 
cell population were accumulated in G2/M phase 
with a decreased population in S and G1 phase. 
Different figure was found in the methanol treated 
group, which showed a lower cell population in G1 
phase accompanied by an increased cell population 
in S phase. The result indicated that MOLT-4 cells 
which initially arrested on G-1 after 24h, were able 
to proceed to the next stage of DNA synthesis in the 
S-phase after 48 h. After 72h, methanol- and 
hexane-treated groups provided a sound evidence 
of cell arrest in G2/M phase, accompanied by a 
decreased of S phase population without any rising 
in G1 cell population. As mentioned earlier, MOLT-
4 cells treated with chloroform and ethanol 
extracts for 24h demonstrated and S-phase arrest. 
However, after 72h treatment, the result is 
comparable to that shown by untreated cells, which 
indicated that the cells were able to escape cell 
cycle arrest and continue the cell proliferation. In 
overall, our result demonstrated that P. niruri 
extracts caused cell arrest at different phases in 
MOLT-4 cell cycle. 
 
Induction of apoptosis of P. niruri in leukemia 
cell lines 
We further evaluated apoptotic induction 
caused by P. niruri, by observing apoptotic cells 
after treatment with methanol extract, which 
demonstrated the most potent anti-proliferative 
activity. Methanol extract induced apoptosis in 
MOLT-4 and K562 cells (apoptotic population was 
77±6.6% and 36.5±8.5% for MOLT-4 and K562, 
respectively) (Figure 2). The percentage apoptotic 
cells significantly increased, characterised by 
specific morphological changes, including 
alteration of membrane integrity, cytoplasmic 
condensation, formation of apoptotic bodies, and 
DNA fragmentation. Cisplatin, a standard 
chemotherapy agent used as control in this study, 
also induced apoptosis in MOLT-4 cells by showing 
apoptotic cell population of 76±10.4 %. However, 
K562 cell showed resistance in cisplatin-induced 
apoptosis  (apoptosis  population   was  6.8±0.3%). 
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Furthermore, we evaluated the expression of 
tumour suppressor gene p53 in leukemia                       
cells treated with P. niruri. There is an                 
emerging evidence of the importance of p53 in 
initiating apoptosis, through a complex pathway 
aiming at eliminating severely damage cells                    
from continuous replication (Hofseth, et al., 2004). 
Our result showed a measurable increase of                     
p53 expression on MOLT-4 after treatment with              
P. niruri extract (Figure 3), indicating the 
involvement of oncosupressor gene p53 in 
inducing apoptosis. In contrast, K562 has an 
undetectable level of p53 in untreated and treated 





Figure 2. Induction of apoptosis by P. niruri 
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In anti-cancer drugs discovery, more than 
60% of chemotherapy agents currently used were 
derived from nature, half of which are listed as 
plant derived compound  (Cragg and Newman, 
2005; David et al., 2012; Shoeb, 2006; Xiao, et al., 
2016). In this study, we evaluated the anti-cancer 
effect of P. niruri, which is known as a rich source of 
phytochemicals (Cragg and Newman, 2005; Sabir 
and Rocha, 2008; Samali, et al., 2012). Anti-cancer 
activity possessed by P. niruri has been associated 
with the presence of polyphenolic compounds in 
the extracts (Sahni et al., 2005; Samali et al., 2012). 
Polyphenolic compounds are known to show a 
potency not only as chemopreventive agents, but 
also exert their effects in cancer signalling 
pathways to activate death signals or apoptosis 
(Cragg and Newman, 2005; Samali, et al., 2012). 
Previous studies have reported the ability of P. 
niruri in inhibiting the growth of several types of 
cancer cells, with no toxic effect towards normal 
cell lines (Huang, et al., 2010; Lee, et al., 2006; 
Sahni, et al., 2005; Tang, et al., 2010). However, the 
study on the bioactivity of P. niruri  on leukemia 
cells is limited. To our knowledge, our study was 
the first to report the antiproliferative effect on 
P.niruri on MOLT-4 and K562. Our results 
demonstrated that P. niruri crude extracts inhibited 
the growth of leukaemia cell lines MOLT-4 and 
K562 in a selective manner, without showing any 
significant inhibitory effect on the growth of 
normal cell line.  
The results from this study have showed the 
variation in the efficacy of P.niruri extracts in 
halting the MOLT4 and K562 cells proliferation. 
Methanol extract demonstrated the highest 
inhibitory potential on MOLT4 cells compared to 
other extracts. Towards K562 cells, hexane extract 
was found to be more potent compared to 
methanol extract in inhibiting the cells growth. The 
variation in the efficacy of P. niruri extracts against 
MOLT4 and K562 in this study may be attributed to 
the differences of the bioactive substances present 
in each extract and/or the characteristic of the 
cancer cell (Puspita, 2015). It has been argued that 
the methanolic extracts are more lethal towards 
cancer cells due to the high solubility of most 
bioactive compounds in organic solvent such as 
methanol and ethanol (Tang, et al., 2010; Wu, et al., 
2009). Methanol extract is rich of polyphenolic 
compounds such as gallic acid, rutin, coumaric acid, 
geraniin, and quercetin (Puspita, 2015; Tang & 
Sekaran). Martens et all., (2008) reported that 
polyphenolic compounds such as gallic acid, 
coumaric acid, flavonoids and resveratrol are 
responsible for the cytotoxicity of wine extract on 
MOLT-4 cells in a concentration dependant manner 
(Mertens-Talcott, et al., 2008). The authors further 
suggested that antiproliferative effect were more 
likely to be related to the combination of the 
polyphenolic compounds rather than the 
composition of single compound (Mertens-Talcott, 
et al., 2008). With regards to the anticancer effect 
of methanolic extracts, a number of studies 
suggested that anti-proliferative activity of 
polyphenolic compounds is strongly related to 
antioxidant activity the compounds, weather in 
single or combination form (Mertens-Talcott, et al., 
2008).  
Hexane is a nonpolar solvent; therefore, the 
bioactive compounds present in hexane extracts 
 
 
Figure 3. The effect of P. niruri methanol extract on the total p53 expression. 
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are of nonpolar secondary metabolites (Puspita, 
2015). On leukemia cells, hexane extracts from 
other plant sources have shown anti-proliferative 
activity on leukemia cells (Harish and 
Shivanandappa, 2006; Islam, et al., 2008; 
Parvathaneni, et al., 2014; Sangkaruk, et al., 2017). 
For example, hexane fraction extracted from 
M.seamensis flower have shown anti-proliferative 
activity by inhibiting the growth of K562 via 
suppression of WT1 and Bcr/Abl proteins 
(Sangkaruk, et al., 2017). Most of secondary 
metabolites isolated from hexane extract of P.niruri 
were of lignans compounds, including hyllanthin, 
hypophyllanthin, triacontanal and tricontanol 
(Harish and Shivanandappa, 2006). These lignans 
are well known for the anticancer properties. 
Hypophyllanthin and phyllanthin isolated from 
Phyllanthus amarus showed a dose-dependent 
inhibitory on breast cancer cell growth (MDA-MB-
231 and MCF7) (Parvathaneni, et al., 2014). 
Lignans from the same herb has exerted a 
preventive and curative role in Ehrlich Ascites 
Carcinoma in Swiss albino mice (Islam, et al., 2008). 
Amongst all extracts tested, our results showed 
that the hexane extract of P. niruri was most potent 
in inhibiting the proliferation of K562 cells, which 
is coherent with that has been reported elsewhere 
(Huang, et al., 2010; Puspita, 2015). Hexane 
extracts contains triterpenoids, such as gliochidone 
and lupeol, which has been reported to show 
cytotoxic effect towards K562 cell lines (Sakkrom, 
et al., 2010). Moreover, hexane extract of P.amarus, 
a close species to P.niruri, and its lignans derivates, 
including phyllanthin, nirtetralin, and niranthin, 
exerted a significant cytotoxic effect on K562 cells 
(Leite, et al., 2006). The anticancer effect of hexane 
extracts was suggested due to the ability to inhibit 
P-glycoprotein (Pgp) activity (Leite, et al., 2006). 
Pgp is a plasma membrane protein which highly 
expressed in drug-resistant cells. K562 has an 
extensive expression of Pgp on the membrane 
surface (Klein, et al., 1976), therefore might explain 
the anti-cancer potential of the hexane extract 
against K562, as well as the collaborative effect of 
the containing non-polar compounds in inhibiting 
the proliferation of K562 cells.  
The discovery of effective chemotherapy for 
cancer is extremely challenging, as cancer cells 
possess the unique ability to escape apoptosis 
(Evan and Vousden, 2001; Fulda and Debatin, 
2006; Puspita, 2015). Cancer cells have developed 
resistance towards many anti-cancer drugs 
because of this unique ability (Brown and Wouters, 
1999). Accordingly, one of the goals of 
chemotherapy is the re-activation of programmed 
cell death, which cause cell arrest at one phase 
during the cell cycle (Ma, et al., 2014; Shoeb, 2006). 
Our result showed that all P. niruri extracts caused 
the accumulation of MOLT-4 cells in G1-phase and 
disruption of the cell cycle progress to enter S-
phase. Whilst some of cells were able to proceed to 
the next cell cycle phases, methanol extract of 
P.niruri demonstrated a potency to halt cell 
progression to cell division though G2/M phase 
arrest. Consequently, arrested cells in each phase 
within cell cycle will undergo a programmed cell 
death of apoptosis. 
This alteration of cell cycle progression is a 
result form the bioactivity of the active constituents 
present in P.niruri extracts. As previously 
mentioned, Polyphenolic compounds exerted a 
promising potential as chemopreventive and 
chemotherapeutic agents, mostly due to the ability 
in interfering with cell cycle kinetics, altering the 
cell signalling pathways, and activating apoptosis 
(Cragg and Newman, 2005; Fresco, et al., 2006; 
Samali, et al., 2012). The definite mode of action of 
plant extract may not be a result from a single 
active compound, but rather comprise of multiple 
phytochemicals action to induce the observe 
effects. A number of polyphenols, including gallic 
acid and quercetin, were reported to be abundantly 
present in P.niruri extracts (Calixto, et al., 1998; 
Cragg and Newman, 2005). Gallic acid has showed 
a potency to induce G1-arrest and apoptosis in 
human prostate carcinoma cell line via Cip1/P21 
induction (Agarwal, et al., 2006). Moreover, gallic 
acid was able to decrease the level of cytokines 
essential for cell cycle progression, such as CDK4, 
CDK6, and CDK2 (Agarwal, et al., 2006). It has been 
previously reported that quercetin showed a 
potency in inhibiting leukemia cell lines through 
G2/M phase arrest, resulting in the alteration of cell 
cycle progression and  inducing caspase dependent 
apoptotic cell death (Lee, et al., 2006). Accordingly, 
inhibition of MOLT4 and K562 cell cycle may be a 
result from various active ingredients contains in 
P.niruri extracts, involving multiple anti-cancer 
pathways. 
In response to anti-cancer therapy, p53 
plays an important role during cellular checkpoints 
within cell cycle to induce apoptosis (Fulda and 
Debatin, 2006; Lowe, et al., 1994; Ma, et al., 2014). 
Checkpoint function is mediated by genes it 
transcriptionally regulated, including P21, and 
keeps cells from progressing during cell cycle from 
G1 to S-phase or G2 to M-phase after DNA damage 
(Fulda and Debatin, 2006; Lowe, et al., 1994). In 
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leukemia pathogenesis, there is a growing evidence 
of p53 mutation on human lymphoid malignancy, 
allowing leukemic cells to evade apoptosis and 
progress in uncontrolled manner (Gaidano, et al., 
1991). In this study, we showed that apoptotic cell 
population following treatment of MOLT-4 and 
K562 cells with methanol extract of P.niruri was 
markedly increased, showing morphological signs 
of apoptosis, including membrane degradation and 
chromatin condensation. It is therefore suggested 
that methanol extract induced apoptosis in MOLT-
4 and K562 as a result from the checkpoints 
activities and cell arrest during cell cycle. 
Furthermore, our result demonstrated that p53 
expression following MOLT-4 treatment with 
methanol extract was increased, suggesting that 
p53 induction might be involved in MOLT-4 
apoptosis. However, in K562 the changes in p53 
expression was not observed, suggesting that this 
protein has no significant role in the apoptosis 
induced by P.niruri extract. 
There is still a long debate regarding p53 
mechanism in mediating apoptosis (Bunz, et al., 
1999), which is associated with several 
mechanisms, including cross linking with purine 
bases on the DNA, interrupting DNA repair 
mechanisms, stimulating DNA damage, and finally 
causing the apoptosis and cell death (Dasari and 
Tchounwou, 2014). Nevertheless, our finding has 
indicated the involvement of p53 pathway in the 
mechanism of anti-cancer activity exerted by 
methanol extract of P. niruri on MOLT-4 cells. 
However, for K562 cells, which are lacking p53 




The results from this present study have 
highlighted the potency of P. niruri extracts to alter 
the proliferation of leukaemia cell lines MOLT-4 
and K562 in a selective manner. The selectivity was 
shown by the evident cytotoxic effects towards 
cancer cell lines, yet protective towards the normal 
cell line. Although the actual underlying mode of 
actions of P. niruri against leukemia cell lines has 
not been elucidated, the elevated level of p53 has 
indicated that DNA damage following MOLT-4 
treatment with methanol extract has activated the 
p53 pathway to further initiate apoptosis in 
leukaemia cells. Our study has provided an initial 
evidence for the application of P.niruri  in the 
development of plan-derived chemotherapeutic 
agent for leukemia. Nevertheless, further study on 
the apoptosis pathway is needed to reveal the 
mechanism of action of P. niruri against leukemia.  
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